Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease

Figure 2

Comparison of changes of hs-CRP level. Note: The abscissa indicated the time nodes, and the ordinate indicated the level, mg/L. The hs-CRP levels of the CG before treatment, at 4 weeks, 8 weeks, and 12 weeks of treatment were (5.41 ± 2.60), (4.56 ± 1.44), (4.06 ± 1.93), and (3.88 ± 1.60). The hs-CRP levels of the SG before treatment, at 4 weeks, 8 weeks, and 12 weeks of treatment were (5.45 ± 2.63), (3.77 ± 1.12), (3.53 ± 1.05), and (3.41 ± 1.01). ^∗indicates the obvious difference in the hs-CRP level at 4 weeks of treatment between both groups (t = 3.327,  = 0.001).